CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib

por Kagiyama, Yuki, Fujita, Shuhei, Shima, Yutaka, Yamagata, Kazutsune, Katsumoto, Takuo, Nakagawa, Makoto, Honma, Daisuke, Adachi, Nobuaki, Araki, Kazushi, Kato, Ayako, Inaki, Koichiro, Ono, Yoshimasa, Fukuhara, Suguru, Kobayashi, Yukio, Tobinai, Kensei, Kitabayashi, Issay
Publicado 2021

Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma

por Nakagawa, Makoto, Fujita, Shuhei, Katsumoto, Takuo, Yamagata, Kazutsune, Ogawara, Yoko, Hattori, Ayuna, Kagiyama, Yuki, Honma, Daisuke, Araki, Kazushi, Inoue, Tatsuya, Kato, Ayako, Inaki, Koichiro, Wada, Chisa, Ono, Yoshimasa, Yamamoto, Masahide, Miura, Osamu, Nakashima, Yasuharu, Kitabayashi, Issay
Publicado 2018

The molecular basis of myeloid malignancies

por KITAMURA, Toshio, INOUE, Daichi, OKOCHI-WATANABE, Naoko, KATO, Naoko, KOMENO, Yukiko, LU, Yang, ENOMOTO, Yutaka, DOKI, Noriko, UCHIDA, Tomoyuki, KAGIYAMA, Yuki, TOGAMI, Katsuhiro, KAWABATA, Kimihito C., NAGASE, Reina, HORIKAWA, Sayuri, HAYASHI, Yasutaka, SAIKA, Makoto, FUKUYAMA, Tomofusa, IZAWA, Kumi, OKI, Toshihiko, NAKAHARA, Fumio, KITAURA, Jiro
Publicado 2014